Mini Review
Published on 16 May 2017
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treatment of Metastatic Non-Small Cell Lung Cancer, with a Focus on Afatinib
in Thoracic Oncology
![Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treatment of Metastatic Non-Small Cell Lung Cancer, with a Focus on Afatinib](https://www.frontiersin.org/files/myhome article library/245664/245664_Thumb_400.jpg)
- 5,420 views
- 11 citations
Mini Review
Published on 16 May 2017
in Thoracic Oncology
Review
Published on 06 Apr 2017
in Thoracic Oncology
Mini Review
Published on 05 Apr 2017
in Thoracic Oncology
Mini Review
Published on 29 Mar 2017
in Thoracic Oncology
Mini Review
Published on 27 Mar 2017
in Thoracic Oncology
Mini Review
Published on 20 Mar 2017
in Thoracic Oncology
Case Report
Published on 02 Mar 2017
in Thoracic Oncology
Review
Published on 14 Feb 2017
in Thoracic Oncology
Clinical Trial
Published on 20 Dec 2016
in Thoracic Oncology
Mini Review
Published on 14 Nov 2016
in Thoracic Oncology
Case Report
Published on 24 Oct 2016
in Thoracic Oncology
Perspective
Published on 24 Oct 2016
in Thoracic Oncology
Mini Review
Published on 04 May 2016
in Thoracic Oncology
Clinical Trial
Published on 13 Jan 2016
in Thoracic Oncology
Editorial
Published on 30 Nov 2015
in Thoracic Oncology
Review
Published on 30 Sep 2015
in Thoracic Oncology